Point Of Care Infectious Disease Market Report
First published: 11 October 2024 | Last updated: 25 May 2026 | Report Code: point-of-care-infectious-disease
Point Of Care Infectious Disease Market — USD 7.5 billion in 2023, Growing to USD 19.56B by 2033 at 9.7% CAGR
This report provides an extensive analysis of the Point Of Care Infectious Disease market, covering insights into market size, trends, and forecasts from 2023 to 2033, with a focus on regional performance and technological advancements.
Key Takeaways
- Global market expands from $7.50 Billion in 2023 to $19.56 Billion in 2033 with a 9.7% CAGR between 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, increasing from $2.56 Billion in 2023 to $6.67 Billion in 2033.
- Europe grows from $2.27 Billion to $5.91 Billion over the forecast span, reflecting rising diagnostic deployment.
- Asia Pacific advances from $1.53 Billion to $3.99 Billion, driven by improved access and portable testing solutions.
- Major vendors highlighted include Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers, focused on rapid and portable platforms.
Point Of Care Infectious Disease Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report outlines market dynamics for point-of-care infectious disease diagnostics from 2023 to 2033. The market is quantified at $7.50 Billion in 2023 and forecast to reach $19.56 Billion by 2033 at a CAGR of 9.7%. Growth is supported by demand for rapid results, decentralization of testing, and portable molecular and immunoassay innovations. North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. Segmentation covers region, end user, test type, technology, and application, reflecting adoption patterns in hospitals, clinics, home care, and laboratories. Competitive focus centers on established firms such as Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers pursuing product development and market partnerships. The study synthesizes primary interviews and secondary sources to provide actionable insights for strategy, investment, and product planning.
Key Growth Drivers
- Rising need for rapid diagnostics at or near patient care locations accelerates demand for portable POC devices.
- Advances in molecular and immunoassay technologies improve accuracy and broaden test menus for infectious targets.
- Expansion of healthcare infrastructure and access in underserved areas increases adoption of decentralized testing.
- Integration with digital health workflows and telemedicine streamlines result reporting and remote clinical decision-making.
- Investment by manufacturers and partnerships with health systems support product rollout and scale-up.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $7.50 Billion |
| CAGR (2023-2033) | 9.7% |
| 2033 Market Size | $19.56 Billion |
| Top Companies | Roche Diagnostics, Abbott Laboratories, Siemens Healthineers |
| Published Date | 11 October 2024 |
| Last Modified Date | 25 May 2026 |
Point Of Care Infectious Disease Market Overview
Customize Point Of Care Infectious Disease Market Report market research report
- ✔ Get in-depth analysis of Point Of Care Infectious Disease market size, growth, and forecasts.
- ✔ Understand Point Of Care Infectious Disease's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Point Of Care Infectious Disease
What is the Market Size & CAGR of Point Of Care Infectious Disease Market Report market in 2023?
Point Of Care Infectious Disease Industry Analysis
Point Of Care Infectious Disease Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Point Of Care Infectious Disease Market Report Market Analysis Report by Region
Europe Point Of Care Infectious Disease Market Report:
Europe grows from $2.27 Billion in 2023 to $5.91 Billion in 2033. Growth is supported by increasing diagnostic integration in healthcare settings, regulatory support for point-of-care adoption, and investments in decentralized testing solutions.Asia Pacific Point Of Care Infectious Disease Market Report:
Asia Pacific grows from $1.53 Billion in 2023 to $3.99 Billion in 2033. Progress is driven by broader access to healthcare services, demand for portable testing in remote locations, and technology transfer from global suppliers.North America Point Of Care Infectious Disease Market Report:
North America is largest regional market, rising from $2.56 Billion in 2023 to $6.67 Billion in 2033. Regional strength reflects extensive clinical infrastructure, early adoption of rapid diagnostic platforms, and strong presence of leading vendors supporting deployment.South America Point Of Care Infectious Disease Market Report:
Latin America grows from $0.46 Billion in 2023 to $1.19 Billion in 2033. Market expansion is influenced by efforts to strengthen infectious disease detection capacity and deployment of accessible point-of-care platforms.Middle East & Africa Point Of Care Infectious Disease Market Report:
Middle East and Africa grows from $0.69 Billion in 2023 to $1.8 Billion in 2033. Regional uptake is supported by initiatives to improve testing coverage, investments in healthcare infrastructure, and use of portable diagnostics in underserved areas.Tell us your focus area and get a customized research report.
Research Methodology
Point Of Care Infectious Disease Market Analysis By Test Type
The market segmentation by test type shows significant differentiation in performance. Molecular tests, being the most accurate, accounted for $4.67 billion in 2023 and are expected to rise to $12.19 billion by 2033, holding a share of 62.32%. Meanwhile, serological tests are projected to grow from $1.93 billion to $5.02 billion, reflecting their essential role in disease diagnosis.
Point Of Care Infectious Disease Market Analysis By Technology
The technology segment reflects diverse innovations, with immunoassays leading the market with a size of $4.67 billion in 2023, projected to reach $12.19 billion by 2033, constituting 62.32% of the market share. Other technologies such as nucleic acid amplification are also significant contributors.
Point Of Care Infectious Disease Market Analysis By Application
Applications range across various infectious diseases, and HIV testing shows the largest market size, expected to grow from $3.86 billion in 2023 to $10.07 billion by 2033. Tuberculosis testing and hepatitis testing also contribute significantly to the market landscape.
Point Of Care Infectious Disease Market Analysis By End User
Hospitals emerge as the primary end-user segment, with growth anticipated from $3.86 billion to $10.07 billion. Clinics and home care are also gaining traction, reflecting a shift towards decentralized diagnostic approaches.
Point Of Care Infectious Disease Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Point Of Care Infectious Disease Industry
Roche Diagnostics:
A global leader in in-vitro diagnostics, Roche offers a wide range of POC infectious disease testing solutions, integrating innovative technologies.Abbott Laboratories:
Abbott is renowned for its cutting-edge diagnostic tools and has significantly contributed to the POC market, especially in molecular diagnostics.Siemens Healthineers:
Specializing in medical technology, Siemens Healthineers provides advanced POC testing instruments and solutions focusing on infectious diseases.We're grateful to work with incredible clients.
FAQs
What is the market size of the Point Of Care Infectious Disease Market Report in 2023?
The market size in 2023 is $7.50 Billion, based on the reported market valuation at the start of the forecast period.
What is the expected market size of the industry in 2033?
By 2033 the market is projected to be $19.56 Billion, reflecting expansion over the 2023 to 2033 forecast window.
What is CAGR for the forecast period?
The compound annual growth rate for 2023 to 2033 is 9.7%, as specified for the market projection period.
Is there a single fastest Growing region in the Point Of Care Infectious Disease Market Report market?
No single fastest-growing region is stated for the Point Of Care Infectious Disease Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
How big is the market in Europe during the forecast?
Europe's market moves from $2.27 Billion in 2023 to $5.91 Billion in 2033, indicating sustained investment in diagnostic capabilities.
Which companies are highlighted in the report?
Top companies named include Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers, noted for their roles in rapid diagnostic development.
Who contributed to the research methodology?
Research relied on primary interviews with industry experts and secondary sources such as company reports and publications, plus internal validation.
What are common end users covered in the segmentation?
Segment coverage includes hospitals, clinics, home care, and laboratories as the principal end-user categories for point-of-care infectious diagnostics.
What is driving adoption in Asia Pacific?
Adoption in Asia Pacific is influenced by improved access and demand for portable testing, with the market growing from $1.53 Billion in 2023 to $3.99 Billion in 2033.
What test types are included in the market segmentation?
The report lists molecular tests, serological tests, and diagnostics kits among the test-type segments evaluated across the market.